Clinical trial
Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in…
NCT00079417 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00079417 |
|---|---|
| Title | Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma |
| Official title | Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intraocular Retinoblastoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Carboplatin, Cryosurgery, Infrared Laser Therapy, Iodine I-125, Radiation Therapy, Ruthenium Ru-106, Vincristine Sulfate |
| Enrollment | 28 |
| Start date | Dec 26, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Mar 31, 2017 |
| First posted | Mar 10, 2004 |
| Last update posted | Mar 13, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: